Does the combination of hyperthermia with low LET (linear energy transfer) radiation induce anti-tumor effects equivalent to those seen with high LET radiation alone?

References

• Hall EJ, Giaccia AJ, editors. Radiobiology for the radiologist. 7th ed. Philadelphia (USA): Lippincott, Williams & Wilkins; 2012.
   Google Scholar
• van der Kogel AJ, Joiner M, editors. Basic clinical radiobiology for radiation oncologists. 5th ed. London (UK): Hodder Arnold; 2019.
   Google Scholar
• Horsman MR, Mortensen LS, Petersen JB, et al. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9(12):674–687.
   PubMed Web of Science ®Google Scholar
• Siemann DW, Horsman MR. Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacol Ther. 2015;153:107–124.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49(23):6449–6465.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Vaupel P. Pathophysiological basis for the formation of the tumor microenvironment. Front Oncol. 2016;6:66.
   PubMed Web of Science ®Google Scholar
• Zhang S, Guo H, Zhang D, et al. Microcirculation patterns in different stages of melanoma growth. Oncol Rep. 2006;15(1):15–20.
   PubMed Web of Science ®Google Scholar
• López-Camarillo C, Ruiz-Garcia E, Starling N, et al. Editorial: neovascularization, angiogenesis and vasculogenic mimicry in cancer. Front Oncol. 2020;10:1140.
   Web of Science ®Google Scholar
• Chang YS, di Tomaso E, McDonaold DM, et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA. 2000;97(26):14608–14613.
   PubMed Web of Science ®Google Scholar
• Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res. 1986;46:467–473.
   PubMed Web of Science ®Google Scholar
• Moulder JE, Rockwell S. Hypoxic fractions of solid tumors. Int J Radiat Oncol Biol Phys. 1984;10(5):695–712.
   PubMed Web of Science ®Google Scholar
• Barendsen GW. Responses of cultured cells, tumours and normal tissues to radiations of different linear energy transfer. Curr Topics Radiat Res Q. 1968;4:293–356.
   Google Scholar
• Wenzl T, Wilkens JJ. Modelling of the oxygen enhancement ratio for ion beam radiation therapy. Phys Med Biol. 2011;56(11):3251–3268.
   PubMed Web of Science ®Google Scholar
• https://www.ptcog.ch/index.php/facilities-in-operation.
   Google Scholar
• Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol). 2007;19(6):418–426.
   PubMed Web of Science ®Google Scholar
• Elming PB, Sørensen BS, Oei AL, Franken NAP, et al. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers. 2019;11(1):60.
   PubMed Web of Science ®Google Scholar
• Robinson JE, Wizenberg MJ, McCready WA. Combined hyperthermia and radiation suggest and alternative to heavy particle therapy for reduced oxygen enhancement ratios. Nature. 1974;251(5475):521–522.
   PubMed Web of Science ®Google Scholar
• Gerner EW, Leith JT. Enteraction of hyperthermia with radiations of different linerar energy transfer. Int J Radiat Biol Relat Stud Phys Chem Med. 1977;31(3):283–288.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Schneider R, et al. Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale. Int J Hyperthermia. 2014;30(7):524–530.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Overgaard M, Nielsen OS, et al. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo. Br J Cancer. 1982;46(6):904–911.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Chaplin DJ, Overgaard J. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumour cells. Cancer Res. 1990;50(23):7430–7436.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol. 1998;46(2):135–146.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Rojas AM, Saunders MI, BCON investigators, et al. BCON Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial. Radiother Oncol. 2009;91(1):120–125.
   PubMed Web of Science ®Google Scholar
• Janssens GO, Rademakers SE, Terhaard CH, et al. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial. J Clin Oncol. 2012;30(15):1777–1783.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys. 1980;6(11):1507–1515.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Overgaard J. Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo. Int J Hyperthermia. 1987;3(1):79–91.
   PubMed Web of Science ®Google Scholar
• Horsman MR. The therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation. Int J Hyperth. 2015;31(5):453–459.
   PubMed Web of Science ®Google Scholar
• Horsman MR. Realistic biological approaches for improving thermoradiotherapy. Int J Hyperthermia. 2016;32(1):14–22.
   PubMed Web of Science ®Google Scholar
• Sørensen BS, Horsman MR, Alsner J, et al. Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model. Acta Oncol. 2015;54(9):1623–1630.
   PubMed Web of Science ®Google Scholar
• Iwata K, Shakil A, Hur W, et al. Tumour pO2 can be increased markedly by mild hyperthermia. Br J Cancer. 1996;74(Suppl. XXVII):S217–S221.
   Google Scholar
• Horsman MR, Overgaard J. Can mild hyperthermia improve tumour oxygenation? Int J Hyperthermia. 1997;13(2):141–147.
   PubMed Web of Science ®Google Scholar
• Vaupel PW, Kelleher DK. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int J Hyperthermia. 2010;26(3):211–223.
   PubMed Web of Science ®Google Scholar
• Sen A, Capitano ML, Spernyak JA, et al. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res. 2011;71(11):3872–3880.
   PubMed Web of Science ®Google Scholar
• Winslow TB, Eranki A, Ullas S, et al. A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy. Int J Hyperthermia. 2015;31(6):693–701.
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44:4721–4730.
   PubMed Web of Science ®Google Scholar
• Howard-Flanders P, Moore D. The time interval after pulsed irradiation within which injury in bacteria can be modified by dissolved oxygen. I. A search for an effect of oxygen 0.002 seconds after pulsed irradiation. Radiat Res. 1958;9(4):422–437.
   PubMed Web of Science ®Google Scholar
• Michael B, Adams G, Hewitt H, et al. A post-effect of oxygen in irradiated bacteria: a submillisecond fast mixing study. Radiat Res. 1973;54(2):239–251.
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol. 2001;77(4):399–408.
   PubMed Web of Science ®Google Scholar
• Roti Roti JL. Introduction: radiosensitization by hyperthermia. Int J Hyperthermia. 2004;20(2):109–114.
   PubMed Web of Science ®Google Scholar
• Ihara M, Takeshita S, Okaichi K, et al. Heat exposure enhances radiosensitivity by depressing DNA-PK kinase activity during double strand break repair. Int J Hyperth. 2014;30:102–109.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia. 2005;21(8):779–790.
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Song CW. Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia. 2004;20(2):163–174.
   PubMed Web of Science ®Google Scholar
• Song CW, Park HJ, Lee CK, et al. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia. 2005;21(8):761–767.
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Poulson JM, Gaskin AA, et al. Temperature-dependent changes in physiological parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys. 2000;46(1):179–185.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 1996;56:5347–5350.
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Rosen EL, Blackwell KL, et al. Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperth. 2003;19(5):498–506.
   PubMed Web of Science ®Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, et al. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res. 2004;10(13):4287–4293.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Overgaard M. Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. Int J Hyperthermia. 1987;3(6):483–501.
   PubMed Web of Science ®Google Scholar
• van Leeuwen CM, Oei AL, Chin KWTK, et al. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer. Radiat Oncol. 2017;12(1):75.
   PubMed Web of Science ®Google Scholar
• Kroesen M, Mulder HT, van Holthe JML, et al. The effect of the time interval between radiation and hyperthermia on clinical outcome in 400 locally advanced cervical carcinoma patients. Front Oncol. 2019;9:134.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419–R472.
   PubMed Web of Science ®Google Scholar
• Iversen AB, Busk M, Horsman MR. Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy. Acta Oncol. 2013;52(7):1320–1326.
   PubMed Web of Science ®Google Scholar
• Grau C, Durante M, Georg D, et al. Particle therapy in Europe. Mol Oncol. 2020;14(7):1492–1499.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Some problems related to the clinical use of thermal isoeffect doses. Int J Hyperthermia. 1987;3(4):329–336.
   PubMed Web of Science ®Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys. 1989;16(3):535–549.
   PubMed Web of Science ®Google Scholar
• Siemann DW, Chaplin DJ, Horsman MR. Realizing the potential of vascular targeted therapy: the rationale for combining vascular disrupting agents and anti-angiogenic agents to treat cancer. Cancer Invest. 2017;35(8):519–534.
   PubMed Web of Science ®Google Scholar